DIAGNOS proporciona actualización sobre su aplicación CARA AI que participa en el programa de análisis de datos del llamado a la acción de la Casa Blanca

Brossard, Quebec, Canada – April 27th, 2020 – DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture:ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence(AI) tools, provides an update on its CARA...

Software de Inteligencia Artificial CARA

Disclaimer.The CARA system is intended to help qualified healthcare professionals with the analysis of the human retina. When using CARA, the user must be aware of the following: CARA has been approved by Health Canada and the U.S. Food and Drug Administration (FDA)...
Abrir chat
Gracias por venir ¿En que te puedo ayudar?
Powered by